ESR1 and breast carcinoma: However, the fact that, in contrast to ER + disease, we did not observe any significant correlation between pnSTING and immune markers and identified an uncoupling of STING expression and interferon responses in ER- breast cancer suggests that the prognostic role of pnSTING may be more specific to ER + disease.